十大网赌网站注册app网·主頁欢迎您

    <output id="zikax"><ruby id="zikax"><xmp id="zikax"></xmp></ruby></output>

  1. <p id="zikax"><del id="zikax"></del></p>
    <output id="zikax"></output>
    1. <acronym id="zikax"><label id="zikax"></label></acronym>
    2. Archive Videos

      Gastric Disorders Educational Programming


      Dysepsia: A Critical Appraisal

      Program no. MA-0712M, 120 minutes Presenters: David Metz, MD; Charles Sninsky, MD; Peter F. Malet, MD; Donald O. Castell, MD; Henry P. Parkman, MD
      A group of leading physicians discuss pathophysiology and treatment of dyspepsia caused by H. pylori infection and gallbladder dysfunction, motility abnormality of the small bowel and gastroduodenal motility dysfunction, and endoscopy negative GERD as a cause of dyspepsia.

      $289.00 USD

      Liver Disease: Hepatitis B & C

      Program no. MA-0712M, 120 minutes Presenters: Gary Trey, MD; Robert Carithers, MD; Eugene Schiff, MD; Howard Rosenblate, MD; Luis Balart, MD; Raymond Koff, MD; Terressa Wright, MD
      Clinical overview of B&C, extra hepatic manifestations, vaccines for B, standard treatment and early treatment in asymptomatic patient Antibodies and use of PCR diagnostically, liver biopsy and prognastic indicators, hepatitis in Immunosuppressed patients: transplant recipients and HIV patients.

      $289.00 USD

      Cancer Update: Colorectal Cancer

      Program no. MC-0213M, 90 minutes Presenters: Nicholas Petrelli, MD,FACS - Neal Meropol, MD - Tyvin Rich, MD - Alan Venook, MD
      Intro on the Management of Advanced Breast Cancer and the Use of Standard Chemotherapy; Current Hormonal Therapy and New Hormonal Agents in the Management of Breast Cancer; New Agents, including Taxol and Taxotere; Use of Navelbine and Clinical Trial Results.

      $249.00 USD

      Recent Advances in the Management of IBS (Irritable Bowel Syndrome)

      Program no. ME-1001M, 90 minutes Presenters: Douglas Drossman, MD; Howard Mertz, MD; William Whitehead, PhD; W. Grant Thompson, MD; Brenda Toner, PhD
      Describe the application of symptom-based criteria for diagnosis of IBS; Characterize the role of dysmotility and visceral hypersensitivity in IBS; Care of patients with IBS; Role of pharamacotherapeutic agents.

      $249.00 USD
      MEDIVISION ? does not warrant the accuracy of this information, and it is intended as a supplement to, and NOT a substitute for, the knowledge, skill, and judgment of healthcare professionals. If you have questions about health care, please consult a physician or other health care professionals.
      十大网赌网站注册app网